Variant report
Variant | nsv961402 |
---|---|
Chromosome Location | chr2:46656702-46658194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:8)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr2:46657448-46657466 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr2:46656925-46657151 | K562 | blood: | n/a | n/a |
3 | FOXA1 | chr2:46657656-46657859 | T-47D | breast: | n/a | n/a |
4 | GTF2F1 | chr2:46657369-46657378 | K562 | blood: | n/a | n/a |
5 | MAX | chr2:46655848-46656962 | K562 | blood: | n/a | n/a |
6 | MYC | chr2:46655849-46656842 | K562 | blood: | n/a | n/a |
7 | MYC | chr2:46655992-46656848 | K562 | blood: | n/a | n/a |
8 | NR2F2 | chr2:46655851-46656783 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr2:46657180-46657380 | K562 | blood: | n/a | n/a |
10 | POLR2A | chr2:46657791-46657793 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr2:46655752-46656716 | K562 | blood: | n/a | n/a |
12 | TBP | chr2:46655740-46656715 | K562 | blood: | n/a | n/a |
13 | TEAD4 | chr2:46655624-46656734 | K562 | blood: | n/a | n/a |
14 | ZMIZ1 | chr2:46657363-46657377 | K562 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:46656214..46657827-chr2:46704173..46707018,3 | K562 | blood: | |
2 | chr2:46655601..46658738-chr2:47401405..47405423,5 | K562 | blood: | |
3 | chr2:46633942..46636867-chr2:46657432..46660033,3 | K562 | blood: | |
4 | chr2:46524680..46526500-chr2:46655060..46657015,2 | K562 | blood: | |
5 | chr2:46633942..46636424-chr2:46657432..46659768,2 | K562 | blood: |
(count:8 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC018682.6.1-1 | chr2:46657315-46657342 | XLOC_001455 |
2 | lnc-AC018682.6.1-1 | chr2:46657313-46657372 | XLOC_001455 |
3 | lnc-AC018682.6.1-1 | chr2:46657315-46657372 | XLOC_001455 |
4 | lnc-AC018682.6.1-1 | chr2:46657315-46657342 | XLOC_001455 |
5 | lnc-AC018682.6.1-1 | chr2:46657315-46657342 | XLOC_001455 |
6 | lnc-AC018682.6.1-1 | chr2:46657315-46657342 | XLOC_001455 |
7 | lnc-AC018682.6.1-1 | chr2:46657315-46657342 | XLOC_001455 |
8 | lnc-AC018682.6.1-1 | chr2:46657315-46657372 | NONHSAT147088 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TMEM247 | TF binding region |
ENSG00000143933 | chromatin interactions |
ENSG00000187600 | chromatin interactions |
ENSG00000116016 | chromatin interactions |
EFNA3 | miRNA target sites |
TRAF6 | miRNA target sites |
VLDLR | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537310793 | chr2:46656710-46656711 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs112266424 | chr2:46656762-46656763 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs189489697 | chr2:46656767-46656768 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs181035735 | chr2:46656808-46656809 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs185920919 | chr2:46656811-46656812 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs573225985 | chr2:46656812-46656813 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs12475015 | chr2:46656819-46656820 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs565254413 | chr2:46656822-46656823 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs190828010 | chr2:46656832-46656833 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs75436293 | chr2:46656847-46656848 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs550853985 | chr2:46656849-46656850 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs181773893 | chr2:46656922-46656923 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs148220570 | chr2:46656928-46656929 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs186132237 | chr2:46656960-46656961 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs566421598 | chr2:46656989-46656990 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs556052274 | chr2:46656990-46656991 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs551771894 | chr2:46656995-46656996 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs141187384 | chr2:46657015-46657016 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs78919841 | chr2:46657041-46657042 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs7557688 | chr2:46657050-46657051 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs7587138 | chr2:46657089-46657090 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs574215052 | chr2:46657102-46657103 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs146186597 | chr2:46657107-46657108 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs553462167 | chr2:46657110-46657111 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs575203220 | chr2:46657111-46657112 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs75260984 | chr2:46657114-46657115 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs565289602 | chr2:46657115-46657116 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs142327692 | chr2:46657122-46657123 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs572059341 | chr2:46657147-46657148 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs190499375 | chr2:46657149-46657150 | Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs561017179 | chr2:46657166-46657167 | Weak transcription Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs529926498 | chr2:46657173-46657174 | Weak transcription Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs546499516 | chr2:46657220-46657221 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs560259374 | chr2:46657224-46657225 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs113407524 | chr2:46657258-46657259 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs72618626 | chr2:46657279-46657280 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs182751867 | chr2:46657325-46657326 | Weak transcription Active TSS Enhancers | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs112340460 | chr2:46657343-46657344 | Weak transcription Active TSS Enhancers | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs537994259 | chr2:46657390-46657391 | Weak transcription Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs34093619 | chr2:46657404-46657405 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs567843256 | chr2:46657443-46657444 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs77224845 | chr2:46657448-46657449 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs553309640 | chr2:46657485-46657486 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs545796796 | chr2:46657521-46657522 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs539139552 | chr2:46657553-46657554 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs186666482 | chr2:46657611-46657612 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs575750308 | chr2:46657613-46657614 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs191112327 | chr2:46657643-46657644 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs550012176 | chr2:46657654-46657655 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs183003758 | chr2:46657657-46657658 | Weak transcription Enhancers Transcr. at gene 5' and 3' | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hypotonia | 17579669 | CNVD |
Hypotonia-Cystinuria syndrome | 16385448 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cystinuria | 17625506 | CNVD |
Breast cancer | 16272173 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:46647800-46658400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:46653600-46657600 | Active TSS | K562 | blood |
3 | chr2:46655600-46657600 | Active TSS | Placenta | Placenta |
4 | chr2:46656600-46661600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr2:46656600-46661800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr2:46657200-46672200 | Enhancers | HepG2 | liver |
7 | chr2:46657400-46657800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr2:46657600-46657800 | Transcr. at gene 5' and 3' | K562 | blood |
9 | chr2:46657600-46658400 | Weak transcription | Placenta | Placenta |
10 | chr2:46657600-46660600 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
11 | chr2:46657600-46660800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
12 | chr2:46657600-46663800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr2:46657800-46658000 | Active TSS | K562 | blood |
14 | chr2:46657800-46658200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr2:46657800-46660600 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
16 | chr2:46658000-46658200 | Flanking Active TSS | K562 | blood |
17 | chr2:46658000-46659800 | Enhancers | Dnd41 | blood |
18 | chr2:46658000-46660600 | Enhancers | Primary T cells from cord blood | blood |
19 | chr2:46658000-46660800 | Enhancers | Primary T helper naive cells from peripheral blood | blood |